DK0951284T3 - Phenylethylminderivater - Google Patents

Phenylethylminderivater

Info

Publication number
DK0951284T3
DK0951284T3 DK97952645T DK97952645T DK0951284T3 DK 0951284 T3 DK0951284 T3 DK 0951284T3 DK 97952645 T DK97952645 T DK 97952645T DK 97952645 T DK97952645 T DK 97952645T DK 0951284 T3 DK0951284 T3 DK 0951284T3
Authority
DK
Denmark
Prior art keywords
dementia
alkyl
hydrogen
compounds
directed
Prior art date
Application number
DK97952645T
Other languages
Danish (da)
English (en)
Inventor
Michael Chorev
Tamar Goren
Yacov Herzig
Jeffrey Sterling
Marta Weinstock-Rosin
Moussa B H Youdim
Original Assignee
Teva Pharma
Yissum Res Dev Co
Technion Res & Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11985296A external-priority patent/IL119852A0/xx
Priority claimed from IL12050997A external-priority patent/IL120509A0/xx
Application filed by Teva Pharma, Yissum Res Dev Co, Technion Res & Dev Foundation filed Critical Teva Pharma
Application granted granted Critical
Publication of DK0951284T3 publication Critical patent/DK0951284T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97952645T 1996-12-18 1997-12-18 Phenylethylminderivater DK0951284T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11985296A IL119852A0 (en) 1996-12-18 1996-12-18 Phenylethylamine derivatives
IL12050997A IL120509A0 (en) 1997-03-24 1997-03-24 Phenylethylamine derivatives
PCT/US1997/023897 WO1998026775A1 (en) 1996-12-18 1997-12-18 Phenylethylamine derivatives

Publications (1)

Publication Number Publication Date
DK0951284T3 true DK0951284T3 (da) 2004-02-16

Family

ID=26323337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952645T DK0951284T3 (da) 1996-12-18 1997-12-18 Phenylethylminderivater

Country Status (12)

Country Link
EP (1) EP0951284B1 (pt)
JP (1) JP4116085B2 (pt)
AT (1) ATE251456T1 (pt)
AU (1) AU5620998A (pt)
CA (1) CA2275371C (pt)
DE (1) DE69725467T2 (pt)
DK (1) DK0951284T3 (pt)
ES (1) ES2208967T3 (pt)
HK (1) HK1022838A1 (pt)
HU (1) HU226526B1 (pt)
PT (1) PT951284E (pt)
WO (1) WO1998026775A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US8097608B2 (en) 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
CA2547053C (en) * 2003-11-25 2014-05-27 Technion Research & Development Foundation Ltd. Compositions and methods for treatment of cardiovascular disorders and diseases
KR20070087025A (ko) * 2005-01-13 2007-08-27 에프. 호프만-라 로슈 아게 유용한 2치환 아민의 신규 1단계 합성법
AU2006216509B8 (en) 2005-02-24 2012-11-01 Technion Research And Development Foundation Ltd Formulations of ladostigil tartrate
AU2006326642B2 (en) 2005-12-09 2012-05-03 Technion Research And Development Foundation Ltd. Use of low-dose ladostigil for neuroprotection
TW200744576A (en) 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
CA3229910A1 (en) * 2021-08-23 2023-03-02 Alexander Shulgin Research Institute, Inc. Fluorinated empathogens
IL311050A (en) 2021-08-23 2024-04-01 Alexander Shulgin Res Institute Inc Deuterated empathogens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6408165A (pt) * 1964-07-17 1966-01-18
US3507962A (en) * 1969-05-09 1970-04-21 Thompson Chem Co Hayward Controlling leafminer insects with selected carbamate insecticides,including 3,5-dimethyl-4-dimethylamino-methyl phenyl-n-methylcarbamate
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0951284A4 (en) 2002-03-20
ES2208967T3 (es) 2004-06-16
JP2001506655A (ja) 2001-05-22
DE69725467T2 (de) 2004-07-22
WO1998026775A1 (en) 1998-06-25
DE69725467D1 (de) 2003-11-13
PT951284E (pt) 2003-12-31
HK1022838A1 (en) 2000-08-25
CA2275371A1 (en) 1998-06-25
AU5620998A (en) 1998-07-15
CA2275371C (en) 2008-07-29
EP0951284B1 (en) 2003-10-08
EP0951284A1 (en) 1999-10-27
HU226526B1 (en) 2009-03-30
HUP0003180A2 (hu) 2001-01-29
JP4116085B2 (ja) 2008-07-09
ATE251456T1 (de) 2003-10-15
HUP0003180A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
PT966435E (pt) Derivados aminoindano
ATE361287T1 (de) Neue indol-2-on derivate
NO994452D0 (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
ATE109466T1 (de) Neue derivate des aminopiperidins, aminopyrrolidins und des aminoperhydroazepins, verfahren zur herstellung und diese enthaltende arzneimittel.
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
IL111245A (en) Cyclic amides and fungicidal compositions containing them
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
NZ338016A (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
HUP9802937A2 (hu) Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
DE69305276D1 (de) Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie
DK0951284T3 (da) Phenylethylminderivater
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
NO307464B1 (no) Galantaminderivater, farmasøytisk sammensetning inneholdende samme samt deres anvendelse for fremstilling av medikamenter
ATE218860T1 (de) Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms
KR970706826A (ko) 포스포디에스테라제 IV 억제제로서의 디아제피노-인돌(Diazepino-Indoles as Phosphodiesterase Ⅳ Inhibitors)
HUP0001093A2 (hu) 5-HT2A-antagonista oxazolidinon-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ATE8144T1 (de) Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
NZ536524A (en) Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
DE69825879D1 (de) Pharmazeutische zusammensetzungen welche aryl-substituierte olefinische amin-verbindungen enthalten
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
FR2729665B1 (fr) Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
DE59308331D1 (de) Verfahren zur Herstellung von 1-unsubstituierten 3-Aminopyrrolen